| Literature DB >> 36091303 |
Takahito Sugase1, Hiroshi Miyata1, Keijiro Sugimura1, Takashi Kanemura1, Tomohira Takeoka1, Masaaki Yamamoto1, Naoki Shinno1, Hisashi Hara1, Takeshi Omori1, Masahiko Yano1.
Abstract
Aim: Dysphagia is one of the most common complications after esophagectomy. However, no study has investigated the long-term postoperative outcomes in patients with postoperative dysphagia. Here, we aimed to identify risk factors for postoperative dysphagia and to investigate long-term postoperative outcomes in such patients.Entities:
Keywords: dysphagia; esophageal cancer; esophagectomy; pneumonia; recurrent laryngeal nerve palsy
Year: 2022 PMID: 36091303 PMCID: PMC9444858 DOI: 10.1002/ags3.12566
Source DB: PubMed Journal: Ann Gastroenterol Surg ISSN: 2475-0328
Evaluation of videofluoroscopic swallowing study
|
Total N = 304 | Postoperative swallowing function | |||
|---|---|---|---|---|
|
Normal N = 192 |
Mild dysphagia N = 101 |
Severe dysphagia N = 11 | ||
| Liquid aspiration, n (%) | ||||
| None | 196 (65) | 192 (100) | 4 (4) | 0 (0) |
| Slight | 98 (32) | 0 (0) | 97 (96) | 1 (9) |
| Severe | 10 (3) | 0 (0) | 0 (0) | 10 (91) |
| Silent aspiration, n (%) | 85 (28) | 0 (0) | 77 (76) | 8 (78) |
| Residue in the pyriform sinus/vallecula, n (%) | ||||
| None | 168 (55) | 145 (76) | 21 (21) | 2 (18) |
| Slight | 103 (34) | 42 (22) | 58 (57) | 3 (27) |
| Severe | 33 (11) | 4 (2) | 23 (22) | 6 (55) |
| Inversion of the epiglottis, n (%) | ||||
| Normal | 212 (70) | 167 (86) | 43 (43) | 2 (18) |
| Slight | 83 (27) | 25 (14) | 54 (53) | 4 (36) |
| None | 9 (3) | 0 (0) | 4 (4) | 5 (46) |
FIGURE 1Diagnostic diagram of postoperative dysphagia
Comparison of preoperative patient characteristics
|
Total N = 304 |
Normal N = 192 |
Dysphagia N = 112 |
|
|---|---|---|---|
| Age, years, median (range) | 66 (41‐80) | 70 (42‐81) | <0.001 |
| Sex, n (%) | |||
| Male/Female | 154/38 (80/20) | 92/20 (82/18) | 0.679 |
| ASA‐PS, n (%) | |||
| 1/2/3 | 4/182/6 (2/95/3) | 2/103/7 (2/92/6) | 0.426 |
| Body composition analysis | |||
| BMI, kg/m2, median (range) | 21.4 (15.4‐30.9) | 20.4 (14.1‐34.6) | 0.026 |
| SMI, kg/m2, median (range) | 9.18 (6.3‐12.8) | 8.69 (6.8‐11.3) | 0.040 |
| BFM, kg, median (range) | 12.4 (3.5‐32.7) | 11.1 (1.6‐29.4) | 0.154 |
| BMR, kcal, median (range) | 1392 (1033‐1814) | 1336 (999‐1799) | 0.179 |
| Difficulty swallowing, n (%) | 70 (36) | 49 (44) | 0.209 |
| Brinkman index, median (range) | 640 (0‐4000) | 750 (0‐3000) | 0.064 |
| Current smoker, n (%) | 74 (39) | 53 (47) | 0.135 |
| %VC, median (range) | 107.9 (67.5‐163.8) | 107.4 (65.8‐158.8) | 0.192 |
| FEV1%, median (range) | 77.7 (53.2‐94.5) | 76.5 (40.7‐100) | 0.124 |
| Living alone, n (%) | 25 (13) | 22 (20) | 0.123 |
| Neoadjuvant therapy, n (%) | |||
| CT/CRT/None | 93/28/71 (48/15/37) | 54/21/37 (48/19/33) | 0.585 |
| Tumor location, n (%) | |||
| Upper/Middle/Lower | 37/101/54 (19/53/28) | 24/58/30 (21/52/27) | 0.896 |
| Histology | |||
| SCC/non‐SCC | 186/6 (97/3) | 110/2 (98/2) | 0.482 |
| (y)cT, n (%) | |||
| 1/2/3/4 | 82/36/72/2 (43/19/37/1) | 35/22/50/5 (31/20/45/4) | 0.074 |
| (y)cN, n (%) | |||
| 0/1‐2 | 102/90 (53/47) | 47/65 (42/58) | 0.060 |
| (y)cM, n (%) | |||
| 0/1 | 174/18 (91/9) | 105/7 (94/6) | 0.339 |
| (y)cStage, n (%) | |||
| I/II/III/IV | 76/40/56/20 (40/21/29/10) | 33/26/40/13 (29/23/36/12) | 0.354 |
Abbreviations: ASA‐PS, American Society of Anesthesiologists physical status; BFM, body fat mass; BMI, body mass index; BMR, basal metabolic rate; CRT, chemoradiotherapy; CT, chemotherapy; FEV, forced expiratory volume; SCC, Squamous cell carcinoma; SMI, Skeletal muscle mass index; VC, vital capacity.
Comparison of surgical outcomes and clinicopathological findings
| Total N = 304 |
Normal N = 192 |
Dysphagia N = 112 |
|
|---|---|---|---|
| Lymphadenectomy, n (%) | |||
| 2‐Field/3‐Field | 51/141 (27/73) | 32/80 (29/71) | 0.705 |
| Reconstruction, n (%) | |||
| Retrosternal/Mediastinal/Antethoracic | 153/26/13 (80/13/7) | 87/20/5 (78/18/4) | 0.463 |
| Anastomosis, n (%) | |||
| Modified Collard/Circular stapler/Hand‐sewn | 138/56/1 (72/27/1) | 80/30/2 (71/27/2) | 0.558 |
| Video‐assisted thoracic surgery, n (%) | 98 (51) | 46 (41) | 0.093 |
| Operation time, minutes, median (range) | 512 (329‐751) | 524.5 (348‐748) | 0.226 |
| Blood loss, ml, median (range) | 297 (10‐2635) | 287.5 (20‐1335) | 0.966 |
| pT, n (%) | |||
| 0/1/2/3/4 | 17/103/17/54/1 (9/53/9/28/1) | 12/46/16/38/0 (11/41/14/34/0) | 0.212 |
| pN, n (%) | |||
| 0/1/2/3 | 105/54/23/10 (55/28/12/5) | 54/39/13/6 (48/35/12/5) | 0.656 |
| pM, n (%) | |||
| 0/1 | 176/16 (92/8) | 105/7 (94/6) | 0.508 |
| pStage, n (%) | |||
| 0/I/II/III/IV | 13/71/44/39/25 (7/37/23/20/13) | 10/28/33/31/10 (9/25/29/28/9) | 0.114 |
Univariate and multivariate Cox model analysis for the postoperative dysphagia
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Odds | 95%CI |
| Odds | 95%CI |
| |
| Age (70≦) | 3.18 | [1.84‐5.50] | <0.001 | 2.94 | [1.75‐4.93] | <0.001 |
| Sex (male) | 1.14 | [0.62‐2.07] | 0.679 | |||
| BMI (<18.5) | 1.95 | [1.09‐3.51] | 0.025 | 1.91 | [1.02‐3.59] | 0.043 |
| SMI (low*) | 1.11 | [0.78‐6.76] | 0.909 | |||
| Esophageal food obstruction | 1.36 | [0.84‐2.18] | 0.210 | |||
| Brinkman index (700≦) | 1.49 | [0.93‐2.38] | 0.097 | 1.33 | [0.80‐2.21] | 0.268 |
| Current smoker | 1.43 | [0.89‐2.29] | 0.135 | |||
| %VC (<80%) | 5.38 | [1.07‐27.11] | 0.042 | 3.46 | [0.64‐18.70] | 0.149 |
| FEV1% (<70%) | 1.12 | [0.62‐2.01] | 0.704 | |||
| Living alone | 1.63 | [0.87‐3.06] | 0.126 | |||
| Neoadjuvant therapy | 1.19 | [0.73‐1.94] | 0.489 | |||
| Tumor location (Upper) | 1.14 | [0.64‐2.03] | 0.651 | |||
| (y)cStage (3‐4) | 1.37 | [0.86‐2.19] | 0.189 | |||
| Non‐video assisted thoracic surgery | 1.50 | [0.93‐2.40] | 0.094 | 1.30 | [0.78‐2.16] | 0.308 |
| Lymphadenectomy (3‐Field) | 1.11 | [0.66‐1.86] | 0.705 | |||
| Reconstruction (non‐retrosternal route) | 1.13 | [0.64‐1.99] | 0.679 | |||
| Anastomosis (Circular stapler) | 1.04 | [0.62‐1.76] | 0.877 | |||
| Anastomosis leakage, n (%) | 1.27 | [0.49‐3.25] | 0.624 | |||
| Recurrent laryngeal nerve palsy | 3.84 | [1.91‐7.73] | <0.001 | 4.48 | [1.73‐11.60] | 0.002 |
Abbreviations: BMI; body mass index, FEV, forced expiratory volume; SMI, Skeletal muscle mass index; VC; vital capacity; *male, <7.0 kg/m2, female;<5.7 kg/m2.
Comparison of short‐term and long‐term postoperative outcomes
| Total N = 304 |
Normal N = 192 |
Dysphagia N = 112 |
| Degree of postoperative dysphagia |
| |
|---|---|---|---|---|---|---|
|
Mild dysphagia N = 101 |
Severe dysphagia N = 11 | |||||
| In‐hospital (short‐term postoperative outcomes) | ||||||
| Pneumonia, n (%) | 14 (7) | 36 (32) | <0.001 | 29 (29) | 7 (64) | 0.019 |
| Recurrent laryngeal nerve palsy, n (%) | 7 (4) | 17 (15) | <0.001 | 13 (13) | 4 (36) | 0.039 |
| Anastomosis leakage, n (%) | 11 (6) | 8 (7) | 0.623 | 6 (6) | 2 (18) | 0.134 |
| Postoperative CRP max, mg/dl, median (range) | 13.24 (4.02‐36.93) | 15.09 (6.03‐36.49) | <0.001 | 15.07 (6.03‐36.49) | 15.18 (7.92‐30.31) | 0.368 |
| Oral intake after surgery, days, median (range) | 8 (7‐113) | 11 (8‐59) | <0.001 | 9 (7‐113) | 22.5 (14‐46) | <0.001 |
| Postoperative hospital stay, days, median (range) | 17 (13‐122) | 21 (15‐74) | <0.001 | 20 (15‐69) | 36 (21‐74) | <0.001 |
| Out‐of‐hospital (long‐term postoperative outcomes) | ||||||
| Pneumonia, n (%) | 14 (6) | 43 (33) | <0.001 | 37 (37) | 6 (55) | 0.246 |
| ≦1year | 7 (4) | 21 (19) | <0.001 | 17 (17) | 4 (36) | 0.081 |
| <1 year | 9 (5) | 24 (21) | <0.001 | 23 (23) | 1 (9) | 0.373 |
| Weight change (%, per pre‐op), median (range) | ||||||
| Post 1‐year | 90.5 (65.9‐107.7) | 88.3 (71.7‐107.2) | 0.228 | 89.6 (67.4‐108.9) | 88.6 (79.5‐96.5) | 0.893 |
| Post 2‐year | 90.8 (58.6‐112.5) | 87.5 (69.8‐105) | 0.039 | 88.7 (66.7‐108.2) | 87.9 (71.8‐97.7) | 0.705 |
| Death from pneumonia, n (%) | 0 (0) | 6 (5) | 0.002 | 6 (6) | 0 (0) | 0.530 |
Abbreviation: CRP, C‐reactive protein.
Univariate and multivariate Cox model analysis for in‐hospital pneumonia
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Odds | 95%CI |
| Odds | 95%CI |
| |
| Age (≦70) | 2.93 | [1.58‐5.43] | <0.001 | 3.08 | [1.35‐7.05] | 0.008 |
| Sex (male) | 1.54 | [0.66‐3.63] | 0.320 | |||
| Preoperative BMI (<18.5) | 1.31 | [0.62‐2.75] | 0.476 | |||
| Brinkman index (≦700) | 1.79 | [0.96‐3.34] | 0.066 | 1.51 | [0.65‐3.49] | 0.336 |
| Current smoker | 1.99 | [1.08‐3.68] | 0.027 | 2.23 | [0.98‐5.09] | 0.058 |
| %VC (<80%) | 3.18 | [0.73‐13.75] | 0.122 | |||
| FEV1% (<70%) | 1.59 | [0.78‐3.23] | 0.200 | |||
| Living alone | 1.13 | [0.37‐2.07] | 0.755 | |||
| Neoadjuvant therapy | 1.21 | [0.63‐2.30] | 0.569 | |||
| Tumor location (Upper) | 1.17 | [0.54‐2.57] | 0.690 | |||
| non‐video assisted thoracic surgery | 1.13 | [0.62‐2.08] | 0.684 | |||
| Lymphadenectomy (3‐Field) | 1.08 | [0.54‐2.16] | 0.821 | |||
| Reconstruction (non‐retrosternal route) | 2.02 | [1.03‐3.96] | 0.040 | 1.04 | [0.38‐2.83] | 0.944 |
| Anastomosis (Circular stapler) | 2.24 | [1.19‐4.21] | 0.012 | 2.15 | [0.85‐5.47] | 0.108 |
| Operation time (≦10 h) | 2.84 | [1.35‐5.97] | 0.006 | 3.06 | [1.12‐8.36] | 0.030 |
| Blood loss (≦500 ml) | 1.45 | [0.74‐2.84] | 0.280 | |||
| pStage (3‐4) | 1.08 | [0.57‐2.03] | 0.812 | |||
| Recurrent laryngeal nerve palsy | 6.80 | [3.29‐14.04] | <0.001 | 32.87 | [9.69‐111.44] | <0.001 |
| Postoperative swallowing function (Dysphagia) | 6.02 | [3.07‐11.81] | <0.001 | 4.05 | [1.78‐9.21] | <0.001 |
Abbreviations: BMI, body mass index; FEV, forced expiratory volume; VC, vital capacity.
Univariate and multivariate Cox model analysis for out‐of‐hospital pneumonia
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| Odds | 95%CI |
| Odds | 95%CI |
| |
| Age (≦70) | 2.39 | [1.28‐4.47] | 0.006 | 1.44 | [0.72‐2.86] | 0.298 |
| Sex (male) | 2.25 | [0.85‐5.95] | 0.104 | |||
| Preoperative BMI (<18.5) | 1.39 | [0.66‐2.94] | 0.383 | |||
| Brinkman index (≦700) | 2.03 | [1.07‐3.86] | 0.030 | 1.79 | [0.90‐3.56] | 0.099 |
| Preoperative current smoker | 1.49 | [0.80‐2.76] | 0.210 | |||
| %VC (<80%) | 1.32 | [0.16‐10.99] | 0.797 | |||
| FEV1% (<70%) | 1.70 | [0.83‐3.46] | 0.146 | |||
| Living alone | 1.32 | [0.59‐2.95] | 0.493 | |||
| Neoadjuvant therapy | 1.11 | [0.58‐2.09] | 0.756 | |||
| Tumor location (Upper) | 1.06 | [0.49‐2.26] | 0.885 | |||
| non‐video assisted thoracic surgery | 1.38 | [0.74‐2.57] | 0.305 | |||
| Reconstruction (retrosternal route) | 1.02 | [0.48‐2.17] | 0.968 | |||
| Anastomosis (Circular stapler) | 1.26 | [0.64‐2.46] | 0.504 | |||
| pStage (3‐4) | 1.17 | [0.62‐2.21] | 0.639 | |||
| Recurrent laryngeal nerve palsy | 3.00 | [1.20‐7.47] | 0.018 | 1.75 | [0.65‐4.73] | 0.271 |
| Postoperative swallowing function (dysphagia) | 8.12 | [3.93‐16.76] | <0.001 | 6.76 | [3.18‐14.37] | <0.001 |
Abbreviations: BMI, body mass index; FEV, forced expiratory volume; VC, vital capacity.